Charles Bronfman, heir to the Seagram fortune, helped lead one of the world’s most powerful liquor empires while building a lasting public profile through philanthropy, cultural patronage, and Jewish causes. As co-chairman of Seagram, he stood at the center of the family business before its landmark sale to Vivendi in 2000, a deal that marked the end of an era for one of Canada’s most iconic corporate dynasties. Bronfman later became as well known for giving as for business, extending his influence far beyond spirits and family wealth.

Noubar Afeyan, founder and CEO of Flagship Pioneering, is a leading biotech entrepreneur and venture creator known for inventing companies at the intersection of science and breakthrough innovation. Through Flagship, he has co-founded and incubated dozens of life-sciences companies, most notably Moderna, helping pioneer the mRNA platform that reshaped vaccine development and global public health. Trained as a chemical engineer, Afeyan combines deep scientific rigor with venture discipline, backing long-horizon technologies across biology, health, and sustainability. His work has made Flagship a cornerstone of modern biotech company creation.

Mortimer Zuckerman, real estate magnate, media executive, and investor, built a multifaceted career spanning property development, publishing, and public policy influence. As longtime chairman and CEO of Boston Properties, he helped create one of the largest publicly traded office real estate investment trusts in the United States, shaping skylines in New York, Boston, and Washington, D.C. In parallel, Zuckerman became a prominent media figure as owner and editor-in-chief of U.S. News & World Report and publisher of the New York Daily News, using his platforms to weigh in on economics, foreign policy, and urban affairs. His career reflects a rare blend of large-scale real estate execution and national media influence.